Home/ Supplements/ Astaxanthin/ K2-D3 with Astaxanthin

K2-D3 with Astaxanthin

product on market Capsule Douglas Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Vitamin D3 and K2 are supported by strong evidence for promoting bone health and calcium regulation. Astaxanthin provides antioxidant support to protect cells from oxidative stress. Together, these ingredients target skeletal and cardiovascular wellness through well-documented biological pathways.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for K2-D3 with Astaxanthin
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Vegetarian Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

62.5 mcg (313% DV)
4.2× RDA — above typical dose (UL: 0.1 mg) 608 studies (A:16, B:251)
2 mg
Market median: 4.0mg (47 products)
180 mcg
1.5× RDA — within safe limits 275 studies (A:9, B:175)

Other Ingredients

Microcrystalline Cellulose Hydroxypropyl Methylcellulose Vegetable Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Usage: Adults take 1 capsule daily with a meal, or as directed by your health professional.

Warnings & Precautions

Warning: If you are pregnant, nursing, have any health condition or taking any medication, particularly blood thinners, consult your health professional before using this product.

Note: People consuming more than 50 mcg (2,000 IU) per day should have their vitamin D blood levels monitored by a health professional.

Keep out of the reach of children.

Use only if safety seal is intact.

Formulation Notes

Gluten-free, Non-GMO

Cardiovascular and bone health

Additional Information

Store in a cool, dry place.

Scan to learn about our manufacturing excellence Contents may not fill package in order to accommodate required labeling. Please rely on stated quantity.

Metadata

Product Details

UPC / SKU3 10539 04063 8
DSLD Entry Date2022-09-22
Product TypeOther Combinations
FormCapsule
DSLD ID274066
Data Updated2026-04-11
Research

Research Evidence

6
Research Sources
44
Avg Quality
5
Clinical Trial
1
Rct
C A combined effect of Cavacurcumin, Eicosapentaenoic acid (Omega-3s), Astaxanthin and Gamma -linoleic acid (Omega-6) (CEAG) in healthy volunteers- a randomized, double-blind, placebo-controlled study.
Rct Clinical nutrition ESPEN PubMed DOI
C Astaxanthin Reduces Exercising Heart Rate.
Clinical Trial ClinicalTrials.gov 2021
C Effects of Astaxanthin Supplementation
Clinical Trial ClinicalTrials.gov 2023
C Evaluation of Astaxanthin Properties on Anti-fatigue
Clinical Trial ClinicalTrials.gov 2022
C Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin Aging
Clinical Trial ClinicalTrials.gov 2018
C Oral Astaxanthin and Semen Quality, Fertilization and Embryo Development in Assisted Reproduction Techniques Procedures
Clinical Trial ClinicalTrials.gov 2014
View all evidence for Astaxanthin →
Compare

Similar Products

View all Astaxanthin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.